Intellectual Property India Publishes Patent Application for 'Belumosudil Metabolites And Uses Thereof In The Treatment Of Chronic Graft-Versus-Host Disease' Filed by Kadmon Corporation, Llc

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202517000520 A) filed by Kadmon Corporation, Llc, Bridgewater, U.S.A., on Jan. 2, for 'belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host disease.'

Inventor(s) include Schueller, Olivier; and Patel, Jeegar.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides metabolites of belumosudil and uses of the metabolites in of treating patients with ROCK2-mediated diseases including cGVHD."

The patent application was internationally filed on July 14, 2022, under International application No...